000 01251 a2200349 4500
005 20250513080551.0
264 0 _c19930326
008 199303s 0 0 eng d
022 _a0006-2952
024 7 _a10.1016/0006-2952(93)90157-r
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSanders, T W
245 0 0 _aLack of in vivo evidence of a cytochrome P450 metabolite participating in aminoglycoside nephrotoxicity.
_h[electronic resource]
260 _bBiochemical pharmacology
_cFeb 1993
300 _a780-2 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntipyrine
_xpharmacokinetics
650 0 4 _aCytochrome P-450 Enzyme System
_xmetabolism
650 0 4 _aGentamicins
_xtoxicity
650 0 4 _aKidney Diseases
_xchemically induced
650 0 4 _aLiver
_xdrug effects
650 0 4 _aMale
650 0 4 _aProtoporphyrins
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
700 1 _aReinhard, M K
700 1 _aJollow, D J
700 1 _aHottendorf, G H
773 0 _tBiochemical pharmacology
_gvol. 45
_gno. 3
_gp. 780-2
856 4 0 _uhttps://doi.org/10.1016/0006-2952(93)90157-r
_zAvailable from publisher's website
999 _c8442048
_d8442048